NDC11 00006385602
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00006-3856-02 | 00006-3856 |
| 00006-3856-2 | 00006-3856 |
| 0006-3856-02 | 0006-3856 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RECARBRIO | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | Merck Sharp & Dohme LLC | be32f468-738b-40df-a425-591e12f65159 | 2025-12-09 | Warnings, Adverse reactions | 0006-3856-02 0006-3856 00006385602 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.